Stock Details
AMGN is Amgen Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 243.39$. Average daily volumn in 3 months 3.35M. Market cap 131.11B

Stock symbol : AMGN. Exchange : NasdaqGS. Currency : USD
Lastest price : 245.44$. Total volume : 210.89k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Amgen Inc. (AMGN)
Last Price

Previous Close245.25
Day Range244.29-245.73
Bid245.49 x 1k
Ask245.54 x 800
Average Volume3.35M
Market Cap131.11B
52 Week Range198.64-258.45
Trailing P/E24.23
Foward P/E12.93
Dividend (Yield %)3.16%
Ex-Dividend Date2022-05-16

Financial Details

According to Amgen Inc.'s financial reports the company's revenue in 2021 were 25.98B an increase(0%) over the years 2020 revenue that were of 25.42B. In 2021 the company's total earnings were 5.89B while total earnings in 2020 were 7.26B(-28.57%).

Loading ...


Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-rel... ated events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behรงet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Market Cap:
Total Assets:
Total Cash:

News about "Amgen Inc."


Kwmg LLC Has $4.05 Million Stake in Amgen Inc. (NASDAQ:AMGN)

Source from : Defense World - 11 hours ago

Kwmg LLC increased its position in shares of Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 11.5% during the first quarter, Holdings reports. The institutional investor owned 16,758 shares of ...See details»


Amgen Inc. (NASDAQ:AMGN) Stake Boosted by Cooper Financial Group

Source from : Defense World - 1 days ago

Cooper Financial Group increased its stake in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 2.4% during the first quarter, HoldingsChannel reports. The firm owned 7,767 shares of the medical research ...See details»


What You Need To Know About Amgen Inc.'s (NASDAQ:AMGN) Investor Composition

Source from : YAHOO!Finance - 6 days ago

The big shareholder groups in Amgen Inc. ( NASDAQ:AMGN ) have power over the company. Institutions often own shares ...See details»


Amgen's Beating the Market -- Here's Why It's a Buy Now

Source from : Nasdaq - 6 days ago

Amgen (NASDAQ: AMGN) is the world's largest biotechnology company by revenue, focusing on using living cells to create a robust product portfolio of biologic medicines to treat serious diseases in ...See details»


How a potential $1.2 billion cancer drug deal helps this East Bay biotech target diseases of aging

Source from : The Business Journals - 1 days ago

Why $AZN's #cancer drug pickup could be a big win for a small company hunting down inflammation and diseases of #aging ...See details»


Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Creative Financial Designs Inc. ADV

Source from : ETF Daily News - 10 days ago

Creative Financial Designs Inc. ADV increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 6.2% in the first quarter, according to the company in its most recent filing with the ...See details»


Flagship Harbor Advisors LLC Sells 210 Shares of Amgen Inc. (NASDAQ:AMGN)

Source from : ETF Daily News - 11 days ago

Flagship Harbor Advisors LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 7.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and ...See details»


Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?

Source from : Yahoo Finance - 2 days ago users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.See details»


Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery

Source from : MedCity News - 8 days ago

ReCode Therapeutics has reeled in $200 million in financing. Big pharmaceutical companies are taking notice of the biotech startupโ€™s technology, which enables lipid nanoparticles to go a wide range of ...See details»


Biotech firm Amgen lays out plans for its Humiraโ€™s biosimilar

Source from : The Financial Express on - 14 days ago

Europe's first approved biosimilar came in, and after 15 more received approval. However, in the eight years after the first U.S. biosimilar launch (2015), 36 have been approved and 22 have launched, ...See details»

Amgen Inc. (AMGN) Management Presents at Goldman Sachs 43rd Annual Global Healthcare Conference

Source from : Seeking Alpha - 21 days ago

Good morning. Thanks everyone for joining us, really pleased to have the Amgen team with us. We have Peter Griffith, CFO and Dave Reese, Head of R&D. With that, earlier this year, actually ...See details»


Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach

Source from : BioPharma Dive - 8 days ago

The two drugmakers joined a long list of investors, including Pfizer and Sanofi, that have been funding the startupโ€™s plan to develop a new type of lipid nanoparticle technology.See details»

Did Mirati Therapeutics Just Leapfrog Amgen?

Source from : - 29 days ago

While there are multiple types of KRAS mutations, Amgen (AMGN) - Get Amgen Inc. Report made history in 2021 by earning the first approval for this high-value target that was once considered ...See details»

Amgen Inc Among Leading Companies in the Male Infertility Pipeline Products Market | Globaldata Plc

Source from : YAHOO!Finance - 14 days ago

Male infertility refers to a male's inability to achieve a pregnancy in a fertile femaleLONDON, June 23, 2022 (GLOBE NEWSWIRE) -- Male infertility is caused due to low sperm production, immobile sperm ...See details»